NCT06766786View on ClinicalTrials.gov

Magnesium Supplementation in Simultaneous Pancreas-Kidney Transplantation

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

January 2, 2008

Primary Completion Date

February 20, 2020

Study Completion Date

February 20, 2020

Conditions
Renal Failure Chronic Requiring DialysisDiabetes Mellitus, with ComplicationsGlomerulosclerosisPancreatic Insufficiency (Exocrine and Endocrine)Transplantation, KidneyPancreas Transplantation
Interventions
DRUG

Magnesium Sulfate high dose

Patients undergoing simultaneous pancreas-kidney (SPK) transplantation who gave their consent were given an intravenous magnesium supplement at a dose of 45-50 mg/kg over the course of an hour during the procedure.

Trial Locations (1)

M13 9WU

Central Manchester University Hospital, Manchester

All Listed Sponsors
collaborator

Central Manchester University Hospitals NHS Foundation Trust (co-sponsor, UK)

UNKNOWN

lead

Dr Olu Bamgbade, MD, FRCPC

OTHER

NCT06766786 - Magnesium Supplementation in Simultaneous Pancreas-Kidney Transplantation | Biotech Hunter | Biotech Hunter